Dimopoulos, M. A., & Goldschmidt, H. (2019). Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): A double-blind, randomised, placebo-controlled phase 3 trial. The lancet, 393(10168), . https://doi.org/10.1016/S0140-6736(18)33003-4
Chicago-Zitierstil (17. Ausg.)Dimopoulos, Meletios A., und Hartmut Goldschmidt. "Oral Ixazomib Maintenance Following Autologous Stem Cell Transplantation (TOURMALINE-MM3): A Double-blind, Randomised, Placebo-controlled Phase 3 Trial." The Lancet 393, no. 10168 (2019). https://doi.org/10.1016/S0140-6736(18)33003-4.
MLA-Zitierstil (9. Ausg.)Dimopoulos, Meletios A., und Hartmut Goldschmidt. "Oral Ixazomib Maintenance Following Autologous Stem Cell Transplantation (TOURMALINE-MM3): A Double-blind, Randomised, Placebo-controlled Phase 3 Trial." The Lancet, vol. 393, no. 10168, 2019, https://doi.org/10.1016/S0140-6736(18)33003-4.